Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry
Drug pricing, looming patent cliffs, dealmaking, and the first year of the second Trump administration dominated conversations at the annual JPMorgan Healthcare Conference in San Francisco. Top executives from drugmakers of all sizes met with…
They ditched fine dining and pharma jobs to open a bakery
Ten minutes before The Weirdoughs opened its doors on a Friday morning, a queue of pastry-hungry customers had formed under its bright yellow awning. The small bakery, located in a quiet residential neighborhood of Serangoon in Singapore, had fewer…
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
Council brings together leading global scientific and clinical experts in metabolic diseases to guide development of Nxera's expanding proprietary pipeline Tokyo, Japan and Cambridge, UK, 20 January 2026 – Nxera Pharma Co. Ltd…
Another alliance of health care and AI signals why pharma stocks should be back in favor
Bristol Myers Squibb and Microsoft 's new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with…
Pharma largely unfazed as Greenland tariffs roil markets
Pfizer CEO Albert Bourla shakes hands with US President Donald Trump on September 30, 2025, in the Oval Office (Win McNamee/Getty Images) Drugmakers, which have spent the past six months reaching tariff deals with Trump, seem to expect some…
Senores Pharma posts 105% PAT in Q3, on a 'secular' revenue mix
As pressure mounts from uncertainties linked to the United States market and tariff policies, Senores Pharmaceuticals saw its growth sustained by a “secular” revenue mix, said Swapnil Shah, Managing Director. The company had…
Wells Fargo & Company Raises BridgeBio Pharma (NASDAQ:BBIO) Price Target to $88.00
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target raised by analysts at Wells Fargo & Company from $84.00 to $88.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has an 'overweight' rating on the…
The big losers at the markets today...
The 50-share NSE Nifty tanked 353 points, or 1.38 per cent, to end at 25,232.50. From the 30-Sensex firms, Eternal declined by 4.02 per cent, followed by Bajaj Finance (3.88 per cent), Sun Pharma, InterGlobe Aviation, Trent, Asian Paints, Mahindra…
Ozempic Brings Back the 'Mac vs PC' Ads for the GLP-1 Era
Novo Nordisk's Ozempic kicked off the GLP-1 craze when it launched in 2018 for the treatment of Type 2 diabetes. For years, the Danish pharma giant held onto its crown as the dominant player in the GLP-1 drug market. But a prolonged shortage and…
Novartis CEO: 'Europe lags behind' on innovation
The investment environment outside Europe is currently “much more favourable”, Narasimhan said in the interview with Bloomberg on the sidelines of the World Economic Forum in Davos. The statement comes against a backdrop of renewed…
Novartis could have a U.S. deal that shields it from tariffs, CEO tells CNBC
Swiss pharmaceutical giant Novartis expects to 'not really' be exposed to tariffs by the middle of the year, CEO Vas Narasimhan told CNBC at Davos. 'We also have an agreement with the US government that excludes us from any tariffs we think,' he…
Roche's Genentech more than doubles investment in North Carolina facility to about $2 billion
Technology Jan 20 (Reuters) - Roche's Genentech said on Tuesday it will more than double its initial investment in a biomanufacturing facility in North Carolina to about $2 billion, as the companies look to further…
Investors' Wealth Erodes by Rs 9.86 Lakh Cr as Stock Markets Tumble
New Delhi: Investors' wealth eroded by Rs 9.86 lakh crore in a single day on Tuesday as stock markets faced heavy drubbing, with the BSE Sensex tumbling 1,066 points, amid escalating geopolitical tensions and unabated foreign fund outflows.
Terrible Tuesday: Sensex tumbles over 1,000 points
tock market benchmark indices Sensex and Nifty tanked over 1 per cent on Tuesday due to heavy selling pressure in market heavyweights Reliance, Bajaj Finance and M&M amid escalating geopolitical tensions. Besides, ongoing weakness in the rupee and…
Sikkim man held in Rs 13,000-crore drug haul case: Here's how the contraband was supplied, processed
The Delhi Police has arrested a 30-year-old “carrier” from Sikkim in connection with a Rs 13,000-crore drug bust case in which cocaine and Thai marijuana were seized while being smuggled into Delhi by a Dubai-based cartel in 2024…
Receive a Daily briefing on Pharma Industry News
Get Started